Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Short term Debt (2018 - 2023)

Historic Short term Debt for Dna X (SONM) over the last 6 years, with Q3 2023 value amounting to $37000.0.

  • Dna X's Short term Debt fell 7482.99% to $37000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $37000.0, marking a year-over-year decrease of 7482.99%. This contributed to the annual value of $147000.0 for FY2022, which is 67.57% down from last year.
  • Latest data reveals that Dna X reported Short term Debt of $37000.0 as of Q3 2023, which was down 7482.99% from $74000.0 recorded in Q2 2023.
  • Over the past 5 years, Dna X's Short term Debt peaked at $10.1 million during Q1 2020, and registered a low of $37000.0 during Q3 2023.
  • For the 5-year period, Dna X's Short term Debt averaged around $1.2 million, with its median value being $148000.0 (2021).
  • In the last 5 years, Dna X's Short term Debt surged by 348404.26% in 2020 and then plummeted by 9824.87% in 2021.
  • Dna X's Short term Debt (Quarter) stood at $9.8 million in 2019, then plummeted by 98.2% to $177000.0 in 2020, then dropped by 16.38% to $148000.0 in 2021, then fell by 0.68% to $147000.0 in 2022, then crashed by 74.83% to $37000.0 in 2023.
  • Its Short term Debt was $37000.0 in Q3 2023, compared to $74000.0 in Q2 2023 and $110000.0 in Q1 2023.